Showing results (311-320 of 322) with videos related to
Sort By:
Pageof 33
Blood Advances|January 28, 2026
Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER studyJason Gotlib, Andreas Reiter, Deepti H Radia, et al.Blood Cancer Journal|March 15, 2018
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasmsValerio De Stefano, Alessandra Carobbio, Vincenzo Di Lazzaro, et al.American Journal of Hematology|November 14, 2019
Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 casesEmanuela Sant'Antonio, Paola Guglielmelli, Lisa Pieri, et al.Blood|January 10, 2022
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemiaJohn Mascarenhas, Heidi E Kosiorek, Josef T Prchal, et al.Blood|September 21, 2022
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemiaEric J Duncavage, Adam Bagg, Robert P Hasserjian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Myeloproliferative neoplasm (MPN) symptom assessment form total symptom score: prospective international assessment of an abbreviated symptom burden scoring system among patients with MPNsRobyn M Emanuel, Amylou C Dueck, Holly L Geyer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 25, 2015
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly Geyer, Robyn Scherber, Heidi Kosiorek, et al.Blood|March 19, 2025
Role of allo-HCT in "nonclassical" MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMTNicola Polverelli, Juan Carlos Hernandez-Boluda, Francesco Onida, et al.Leukemia Research|November 3, 2017
Symptom burden profile in myelofibrosis patients with thrombocytopenia: Lessons and unmet needsAllison H Scotch, Heidi Kosiorek, Robyn Scherber, et al.Haematologica|August 20, 2016
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working GroupHolly L Geyer, Heidi Kosiorek, Amylou C Dueck, et al.Pageof 33